PAUL ONIWE: Open Payments
NPI 1700514718 · SOMERSET, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 38 payments from 5 companies in 2025. Trend: 2023 $120 · 2024 $90 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $286 |
| Collegium Pharmaceutical, Inc. | 5 | $80 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: VRAYLAR, Jornay PM, REXULTI, FANAPT, Qelbree.
Industry payments across NJ — which companies pay providers there.
